Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer
Status:
Terminated
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether platinum-based chemotherapy (either
cisplatin or carboplatin), when given with radiation therapy prior to surgery, is effective
in improving response to treatment in triple negative breast cancer patients. This treatment
is being studied in this type of breast cancer because it does not respond well to commonly
used treatments such as tamoxifen or herceptin.